Atlas Trials

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

Clinical trial NCT04873180 · COMPLETED

Trial details

NCT number
NCT04873180
Sponsor
Sohag University
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2020-01-01
Primary completion
2020-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.